Aristippos Gennadios, Group President Pharma & Consumer at Catalent, Inc. (CTLT), sold 3,290 shares at $103.04 ($339K) on 2022-08-25, disclosed to the SEC on 2022-08-26.
Seasonal sale ($339k) by Group President Pharma & Consumer — this insider has traded CTLT in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.04 | 1,645 | $170K | 50.0% |
| 2 | $103.04 | 1,645 | $170K | 50.0% |
| Total | $103.04 avg | 3,290 | $339K | 100% |
| Filing → |
| CTLT | SELL | 2023-08-25 | $18K | — | Filing → |
| CTLT | SELL | 2023-08-03 | $13K | — | Filing → |
| CTLT | SELL | 2022-07-28 | $43K | — | Filing → |